Lumena Pharmaceuticals
Shire: A Global Innovator in Specialty Biopharmaceuticals.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD355m (Public information from May 2014)
San Diego California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $2.6m | Debt | |
$23.0m | Series A | ||
$45.0m | Series B | ||
$260m Valuation: $260m | Acquisition | ||
Total Funding | CAD92.7m |